Fingerprint
Dive into the research topics of 'Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)
David S. Goldfarb, John C. Lieske, Jaap Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak
Research output: Contribution to journal › Article › peer-review